Harleen K Aujla, MD
Internal Medicine · Merced
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
- Since medical school
- 13 years
- Graduated 2013
Offices
1 location · Merced Turlock Nephrology Med Group Inc. · 2 clinicians in this group
Looking this up.
Hospitals listed: 052584 · 052647 · 052706 · 552647 · 552812 · Emanuel Medical Center · Mercy Medical Center. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Aujla’s office at (209) 723-1020 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A140702 · Current
Licensed to practise in California · since 2016 · expires 2027-05-31 · St. George'S University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
- American Board of Internal Medicine - Nephrology
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Emanuel Medical CenterTurlock, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 2 of 5 · 58% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.231, Oct 2024 – Sep 2025
- Mercy Medical CenterMerced, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 59% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.168, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.364, Oct 2024 – Sep 2025
See every measure and the patient survey for Emanuel Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 7 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.231 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.92 (0 to 1.94) · 622 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.46 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 185.82 (131.99 to 239.65) · 55 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 10.8 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 287 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12 · 365 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.9 · 443 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.3 · 102 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.2 · 1,680 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.03 to 0.44) · 4,151 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.53 (1.2 to 5.87) · 700 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.43) · 734 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 1.04) · 3,326 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.2 · 45 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.908 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.836 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.997 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 307 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 461 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -12.8 · 290 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.8 · 417 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 37.9 · 472 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 20.1 · 524 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.9 to 7.6) · 264 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.7 (7.4 to 12.8) · 264 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 40 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.6 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.2 (10.5 to 19.3) · 257 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.2) · 289 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 14% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 79% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 60% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 39% |
| "YES", patients would definitely recommend the hospital | 58% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Mercy Medical Center
Behind the star rating — Deaths: 0 better, 5 the same, 1 worse of 6 measures. Safety: 3 better, 3 the same, 0 worse of 6 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.168 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.364 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.1 (0.11 to 2.09) · 798 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.74 (0.37 to 1.11) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 69 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 449 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.5 · 544 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11 · 206 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 1,843 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 5,594 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 5,647 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.53 (0.28 to 4.78) · 763 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.35) · 161 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.96 (0.37 to 3.55) · 791 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.67 (0 to 16.88) · 163 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.84 (0.67 to 9.02) · 115 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.92 (0.46 to 3.38) · 273 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.85) · 4,979 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.764 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14 · 31 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.5 · 477 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 62.8 · 511 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 43.6 · 554 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.8 · 462 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.8 to 8.2) · 152 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.7 (8 to 14.1) · 152 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 196 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (10.2 to 19) · 70 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.4) · 413 cases | No different | Jan 2024 – Dec 2024 |
What patients said (394 patients answered, 11% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 2 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$191,052
Medicare paid this office $191,052 for 364 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 4 or more physician visits per month (20 years or older) | 35 | $77,678 | $263 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 150 | $30,673 | $58 |
| Return visit (30+ min) | 136 | $22,985 | $87 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 29 | $14,019 | $219 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 83 | $11,367 | $126 |
See all 9 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 35 | $77,678 | $263 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 150 | $30,673 | $58 |
| Return visit (30+ min) | 136 | $22,985 | $87 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 29 | $14,019 | $219 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 83 | $11,367 | $126 |
| New patient visit (60+ min) | 60 | $9,013 | $150 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 83 | $8,362 | $88 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $3,073 | $96 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 109 | $1,602 | $12 |
Who their Medicare patients are
364 Original Medicare patients in 2024. Average age 73 · Under 65 15% · 85 and older 16% · Women 53% · Also on Medicaid 60% · Health risk score 3.52. Sicker patients than 9 in 10 peers; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 70% · Heart failure 49% · Coronary heart disease 46% · Atrial fibrillation 31% · COPD 29% · Depression 24% · Stroke 21% · Dementia 13% · Cancer 11%.
The office billed $446,656, Medicare allowed $248,179 and paid $191,052; for 1,629 services of 21 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 364 | 1,629 | 73 | 3.52 | $446,656 | $191,052 |
| 2023 | 348 | 1,638 | 74 | 3.68 | $336,695 | $194,950 |
| 2022 | 377 | 1,599 | 75 | 3.15 | $342,487 | $185,314 |
| 2021 | 440 | 1,883 | 74 | 3.02 | $345,955 | $199,371 |
| 2020 | 486 | 2,014 | 74 | 3.27 | $375,546 | $191,102 |
| 2019 | 387 | 1,411 | 74 | 3.54 | $260,871 | $132,572 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 30 | $61,989 | $280 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 173 | $48,155 | $63 |
| Return visit (30+ min) | 119 | $20,515 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 111 | $17,276 | $138 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 22 | $13,701 | $232 |
| New patient visit (60+ min) | 34 | $5,574 | $164 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 55 | $5,483 | $95 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 31 | $4,344 | $103 |
| Dialysis services, 1 physician visit per month (20 years or older) | 13 | $2,761 | $162 |
| Long return visit (40+ min) | 13 | $1,888 | $145 |
| Hemodialysis procedure requiring repeated evaluation | 11 | $1,623 | $81 |
2022: 9 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 26 | $51,718 | $291 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 171 | $39,491 | $57 |
| Return visit (30+ min) | 122 | $25,424 | $100 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 110 | $19,278 | $158 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 21 | $14,550 | $243 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 91 | $10,822 | $83 |
| New patient visit (60+ min) | 36 | $5,418 | $150 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $3,076 | $106 |
| Hemodialysis procedure requiring repeated evaluation | 13 | $1,435 | $84 |
2021: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 220 | $54,173 | $58 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 24 | $33,769 | $296 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 174 | $31,352 | $162 |
| Return visit (30+ min) | 172 | $28,040 | $97 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 28 | $21,442 | $244 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 78 | $7,331 | $84 |
| New patient visit (60+ min) | 39 | $6,628 | $170 |
| Long return visit (40+ min) | 22 | $3,128 | $142 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,429 | $110 |
| Hemodialysis procedure requiring repeated evaluation | 20 | $2,146 | $86 |
| Short return visit (20+ min) | 23 | $1,598 | $67 |
2020: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 265 | $56,676 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 206 | $38,520 | $163 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 21 | $33,154 | $237 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 120 | $12,443 | $86 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 21 | $10,338 | $199 |
| Return visit (30+ min) | 77 | $9,203 | $81 |
| Short return visit (20+ min) | 91 | $7,311 | $53 |
| New patient visit (60+ min) | 53 | $7,253 | $137 |
| Hemodialysis procedure requiring repeated evaluation | 20 | $3,403 | $87 |
| Long return visit (40+ min) | 20 | $2,429 | $121 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $2,038 | $113 |
| Hospital discharge day management, more than 30 minutes | 15 | $1,329 | $89 |
| Telephone medical discussion with physician, 5-10 minutes | 15 | $607 | $36 |
2019: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 188 | $36,064 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 154 | $28,411 | $161 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 16 | $14,561 | $231 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 84 | $9,389 | $84 |
| Short return visit (20+ min) | 80 | $8,451 | $60 |
| Return visit (30+ min) | 63 | $8,377 | $89 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 14 | $6,804 | $194 |
| New patient visit (60+ min) | 35 | $5,825 | $166 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $2,863 | $110 |
| New patient visit (45+ min) | 17 | $2,084 | $123 |
| Hemodialysis procedure requiring repeated evaluation | 14 | $1,691 | $85 |
| Long return visit (40+ min) | 13 | $1,666 | $119 |
| Hemodialysis procedure with physician evaluation | 14 | $1,244 | $59 |
Medicaid work
$98,036 in 2024
Medicaid paid $98,036 for 1,062 billed services this clinician did in 2024, up to 31 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 301 | $57,457 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 585 | $23,009 |
| Return visit (30+ min) | 87 | $7,387 |
| Clinic visit/encounter, all-inclusive | 42 | $7,175 |
| 1ST HOSP IP/OBS HIGH 75 | 31 | $2,268 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 16 | $740 |
| 2024 | 1,062 | 6 | 31 | $98,036 |
| 2023 | 1,478 | 6 | 32 | $102,412 |
| 2022 | 1,292 | 5 | 32 | $87,319 |
| 2021 | 1,335 | 7 | 31 | $89,778 |
| 2020 | 1,222 | 6 | 39 | $69,425 |
| 2019 | 622 | 3 | 30 | $20,160 |
See the largest Medicaid services in earlier years
2023
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 207 | $42,224 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 1,003 | $36,873 |
| Return visit (30+ min) | 147 | $8,754 |
| 1ST HOSP IP/OBS HIGH 75 | 82 | $7,826 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 26 | $4,654 |
| Clinic visit/encounter, all-inclusive | 13 | $2,082 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 183 | $35,574 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 866 | $33,669 |
| Return visit (30+ min) | 159 | $9,994 |
| 1ST HOSP IP/OBS HIGH 75 | 69 | $7,288 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 15 | $794 |
2021
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 149 | $30,293 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 813 | $26,653 |
| 1ST HOSP IP/OBS HIGH 75 | 156 | $14,073 |
| Return visit (30+ min) | 133 | $7,426 |
| Clinic visit/encounter, all-inclusive | 35 | $5,305 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 32 | $5,070 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 17 | $958 |
2020
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 840 | $30,461 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 128 | $18,331 |
| 1ST HOSP IP/OBS HIGH 75 | 182 | $17,412 |
| Return visit (30+ min) | 29 | $1,336 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 16 | $983 |
| Short return visit (20+ min) | 27 | $903 |
2019
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 452 | $11,207 |
| 1ST HOSP IP/OBS HIGH 75 | 113 | $7,266 |
| Short return visit (20+ min) | 57 | $1,687 |
Drugs they prescribed that Part D paid
$198,704
Pharmacies billed $198,704 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
936 generic and 208 brand-name prescriptions · $198,704 in drug cost · 13 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Farxiga | 51 | $59,357 | $1,164 |
| Jardiance | 44 | $41,919 | $953 |
| Lokelma | 16 | $20,060 | $1,254 |
| Sevelamer Carbonate | 82 | $13,258 | $162 |
| Veltassa | 12 | $7,546 | $629 |
See all 25 drugs
| Farxiga | 51 | $59,357 | $1,164 |
| Jardiance | 44 | $41,919 | $953 |
| Lokelma | 16 | $20,060 | $1,254 |
| Sevelamer Carbonate | 82 | $13,258 | $162 |
| Veltassa | 12 | $7,546 | $629 |
| Prosol | 40 | $7,466 | $187 |
| Calcium Acetate | 65 | $4,648 | $72 |
| Bumetanide | 11 | $1,247 | $113 |
| Tamsulosin | 52 | $953 | $18 |
| Furosemide | 115 | $951 | $8 |
| Calcitriol | 38 | $884 | $23 |
| Hydralazine | 40 | $751 | $19 |
| Nifedipine Er | 22 | $723 | $33 |
| Lisinopril | 77 | $425 | $6 |
| Amlodipine Besylate | 69 | $400 | $6 |
| Potassium Chloride | 13 | $359 | $28 |
| Metoprolol | 59 | $349 | $6 |
| Gabapentin | 31 | $327 | $11 |
| Metoprolol | 16 | $319 | $20 |
| Losartan | 48 | $266 | $6 |
| Eszopiclone | 11 | $260 | $24 |
| Pantoprazole | 15 | $200 | $13 |
| Allopurinol | 15 | $199 | $13 |
| Carvedilol | 24 | $69 | $3 |
| Atorvastatin | 11 | $39 | $4 |
Year by year
| 2024 | 1,144 | 202 | None | 18% | $198,704 |
| 2023 | 979 | 140 | None | 15% | $135,930 |
| 2022 | 932 | 143 | 2% (14) | 10% | $97,011 |
| 2021 | 769 | 145 | None | 16% | $72,643 |
| 2020 | 730 | 135 | None | 14% | $88,542 |
| 2019 | 586 | 117 | 0% (0) | 17% | $50,737 |
| 2018 | 134 | 51 | 0% (0) | 13% | $17,904 |
| 2017 | 61 | 16 | 0% (0) | None | $1,664 |
| 2016 | 82 | 20 | 0% (0) | None | $3,369 |
| 2014 | 14 | None | 0% (0) | None | $187 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Sevelamer Carbonate | 96 | $36,358 | $379 |
| Lokelma | 19 | $16,259 | $856 |
| Farxiga | 11 | $15,388 | $1,399 |
| Prosol | 73 | $9,287 | $127 |
| Sevelamer | 12 | $7,941 | $662 |
| Calcium Acetate | 64 | $7,053 | $110 |
| Calcitriol | 47 | $1,562 | $33 |
| Furosemide | 101 | $1,517 | $15 |
| Tamsulosin | 66 | $1,175 | $18 |
| Nifedipine Er | 19 | $1,065 | $56 |
| Hydralazine | 33 | $1,024 | $31 |
| Amlodipine Besylate | 82 | $879 | $11 |
| Carvedilol | 35 | $524 | $15 |
| Losartan | 34 | $499 | $15 |
| Metoprolol | 36 | $412 | $11 |
| Gabapentin | 29 | $349 | $12 |
| Metoprolol | 12 | $316 | $26 |
| Pantoprazole | 17 | $301 | $18 |
| Eszopiclone | 12 | $288 | $24 |
| Sertraline | 15 | $269 | $18 |
| Lisinopril | 22 | $247 | $11 |
| Allopurinol | 11 | $219 | $20 |
2022: 19 drugs
| Sevelamer Carbonate | 70 | $19,184 | $274 |
| Lokelma | 17 | $10,244 | $603 |
| Calcium Acetate | 59 | $5,382 | $91 |
| Prosol | 26 | $2,688 | $103 |
| Calcitriol | 74 | $1,481 | $20 |
| Nifedipine Er | 22 | $857 | $39 |
| Hydralazine | 29 | $835 | $29 |
| Furosemide | 84 | $800 | $10 |
| Amlodipine Besylate | 105 | $705 | $7 |
| Tamsulosin | 47 | $560 | $12 |
| Carvedilol | 39 | $443 | $11 |
| Lisinopril | 54 | $271 | $5 |
| Eszopiclone | 11 | $257 | $23 |
| Gabapentin | 19 | $229 | $12 |
| Losartan | 16 | $157 | $10 |
| Metoprolol | 29 | $157 | $5 |
| Allopurinol | 14 | $60 | $4 |
| Hydrochlorothiazide | 20 | $52 | $3 |
| Sertraline | 13 | $43 | $3 |
2021: 19 drugs
| Prosol | 64 | $8,278 | $129 |
| Sevelamer Carbonate | 54 | $8,203 | $152 |
| Calcium Acetate | 23 | $2,018 | $88 |
| Calcitriol | 46 | $1,108 | $24 |
| Tamsulosin | 54 | $810 | $15 |
| Amlodipine Besylate | 85 | $589 | $7 |
| Hydralazine | 30 | $557 | $19 |
| Carvedilol | 33 | $421 | $13 |
| Furosemide | 66 | $414 | $6 |
| Losartan | 23 | $381 | $17 |
| Minoxidil | 17 | $223 | $13 |
| Metoprolol | 11 | $144 | $13 |
| Lisinopril | 24 | $127 | $5 |
| Allopurinol | 18 | $114 | $6 |
| Metoprolol | 18 | $101 | $6 |
| Diltiazem | 13 | $99 | $8 |
| Gabapentin | 23 | $79 | $3 |
| Sertraline | 12 | $78 | $7 |
| Hydrochlorothiazide | 11 | $71 | $6 |
2020: 15 drugs
| Renvela | 11 | $24,990 | $2,272 |
| Sevelamer Carbonate | 35 | $7,192 | $205 |
| Prosol | 21 | $3,166 | $151 |
| Calcitriol | 66 | $1,363 | $21 |
| Calcium Acetate | 15 | $1,106 | $74 |
| Tamsulosin | 42 | $706 | $17 |
| Hydralazine | 25 | $501 | $20 |
| Furosemide | 68 | $462 | $7 |
| Amlodipine Besylate | 101 | $455 | $5 |
| Carvedilol | 43 | $364 | $8 |
| Losartan | 31 | $266 | $9 |
| Lisinopril | 43 | $231 | $5 |
| Metoprolol | 28 | $99 | $4 |
| Gabapentin | 14 | $75 | $5 |
| Allopurinol | 15 | $62 | $4 |
2019: 14 drugs
| Sevelamer Carbonate | 23 | $11,412 | $496 |
| Prosol | 31 | $5,557 | $179 |
| Calcium Acetate | 20 | $1,616 | $81 |
| Nifedipine Er | 27 | $846 | $31 |
| Potassium Chloride | 23 | $730 | $32 |
| Amlodipine Besylate | 98 | $612 | $6 |
| Tamsulosin | 28 | $427 | $15 |
| Calcitriol | 25 | $357 | $14 |
| Hydralazine | 13 | $308 | $24 |
| Losartan | 34 | $273 | $8 |
| Carvedilol | 22 | $273 | $12 |
| Furosemide | 36 | $272 | $8 |
| Lisinopril | 43 | $171 | $4 |
| Metoprolol | 12 | $133 | $11 |
2018: 4 drugs
| Amlodipine Besylate | 28 | $152 | $5 |
| Ranitidine | 12 | $150 | $13 |
| Carvedilol | 12 | $69 | $6 |
| Lisinopril | 13 | $41 | $3 |
2017: 1 drug
| Amlodipine Besylate | 19 | $91 | $5 |
2016: 2 drugs
| Simvastatin | 12 | $71 | $6 |
| Lisinopril | 12 | $44 | $4 |
Money from drug and device companies
$44 in 2025
| 2025 | 1 | 2 | None | $44 |
| 2022 | 2 | 3 | None | $45 |
| 2021 | 1 | 1 | None | $14 |
| 2019 | 1 | 1 | None | $17 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Ozempic | $44 | 2 payments
|
See all 2 published payments
| Novo Nordisk | Meals · 2025-08-21 | Rybelsus | $22 |
| Novo Nordisk | Meals · 2025-06-05 | Ozempic | $22 |
See earlier years (2022, 2021, 2019)
2022: $45
| AstraZeneca Pharmaceuticals LP | Farxiga | $33 | 2 payments
|
| Vifor Pharma | None | $12 | 1 payment
|
2021: $14
| AstraZeneca Pharmaceuticals LP | Lokelma | $14 | 1 payment
|
2019: $17
| Fresenius USA Marketing | Velphoro | $17 | 1 payment
|
Professional record
- NPI
- 1144661000
- Licence
- CA A140702California A140702: Current · expires 2027-05-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 3351 M St Ste 125, Merced, CA, 95348
- NPI first listed
- 2013-07-08
- NPI last updated
- 2021-05-05
- NPI record certified
- 2021-05-05
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 500 W Hospital Rd, French Camp, CA, 95231